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Chemically modified bases naturally exist in genomic DNA. Research into 
these bases has been invigorated by the discovery of several modified bases 
in the mammalian genome, in particular the oxidised derivatives of 5-
methylcytosine, such as 5-hydroxymethylcytosine and 5-formylcytosine, as 
well as the enzymes that form and process them, such as DNA 
methyltransferases (DNMTs) and the ten-eleven translocation (TET) 
enzymes. In this Review we provide an overview of natural, modified bases 
that have been reported in DNA, our current knowledge of their roles, and the 
techniques that have enabled us to probe their functions. Analytical methods 
have been invaluable in helping advance this field. For example, chemical and 
enzymatic methods have provided the means to detect and decode modified 
bases, giving rise to an expanding array of sequencing approaches. 
Advanced liquid chromatography and tandem mass spectrometry have 
provided the means to detect and quantify modified bases with very high 
sensitivity, increasing the prospects for the discovery of unknown 
modifications. It is already evident that natural, modified DNA bases and their 
associated enzymology are of fundamental importance to normal biology and 
to disease. The next decade promises to yield more insights, discoveries and 
impact from this burgeoning field of research.  
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DNA is a remarkable, functional molecule that has evolved to encode and 
transmit information through multiple dimensions. The primary code stored 
within DNA comprises the four nucleobases adenine (A), guanine (G), 
cytosine (C) and thymine (T) and it’s the linear sequence of these four 
canonical bases that constitutes genetic information. Nature maintains, reads 
and transfers the genetic code through cognate base-pair recognition, a 
principle that was originally proposed by Watson and Crick1 and involves A-T 
and G-C interactions (Figure 1). These interactions are also largely 
responsible for the double helical structure of double-stranded DNA. In fact, 
the primary DNA code can also be read from the major groove and minor 
groove of the DNA double helix. The major groove presents a distinct pattern 
of hydrogen bonds, giving rise to a ‘major groove code’, which reveals the 
specific sequence of base pairs and can be recognized and interpreted by 
proteins such as transcription factors [G].2 This enables the sequence-based 
activation of DNA functions, such as the transcription of a protein-coding gene 
to generate mRNA that is subsequently translated into protein. There is also a 
‘minor groove code’, comprising base-pair specific hydrogen bonds in this 
groove that is narrower that then major groove. Although the major groove is 
predominantly read by proteins, it has been possible to read the primary 
sequence of DNA via synthetic polyamide molecules that bind to the minor 
groove.3  
 
5-methylcytosine (5mC) was probably the first variant of a canonical 
nucleobase to be discovered.4 Since the discovery of 5mC in 1898 more than 
17 modified DNA bases have been reported in the genomes of prokaryotes 
and eukaryotes, including mammals5 (Figure 2). A feature of these 
modifications is that they tend to not interfere with Watson–Crick pairing, but 
to introduce chemical functionality into the major groove of the double helix. 
The introduction of added functionality in the major groove can certainly 
perturb or block protein recognition. This is applied in bacterial warfare 
whereby methylation of specific sequence sites in the host genome, called 
restriction methylation [G], provides protection against self-cleavage by 
special nucleases. However, it is now recognized that site-specific 
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modifications introduced into the major groove of DNA can recruit specific 
proteins (known as ‘readers’) that influence the function of the genome at that 
locus. Given that base modifications can be dynamically incorporated or 
removed by specific enzymes, it is possible that a sophisticated and 
reprogrammable major groove code may contribute to the regulation of the 
genome and all of its functions. Thus, the pattern of DNA base modifications 
may constitute an important layer of reprogrammable information in DNA, 
which is of particular interest in the genomes of higher organisms. In this 
Review we will discuss a number of classes of naturally occurring DNA 
modifications and explain how chemistry can be deployed to detect, map and 
decode these DNA base modifications in the genomic DNA of eukaryotes to 
elucidate their function. 
 
Known modifications of DNA  
 
The following sections gives an overview on eukaryotic DNA 
modifications, subdivided by their canonical base precursor. 
 
Cytosine modifications.  
 
The most studied DNA modification is cytosine methylation. It was discovered 
in 18984 and its existence was confirmed by Johnson and Coghill in 1925, 
who identified it as a hydrolysis product of tuberculinic acid.6 In eukaryotes, 
methylation at the C5 position of cytosine is catalyzed by a class of enzymes 
known as DNA methyltransferases (DNMTs), which use S-
adenosylmethionine (SAM) as the methyl donor. DNMT1 is mainly 
responsible for the maintenance of methylation marks during DNA replication, 
whereas DNMT3a and DNMT3b are involved in the methylation of new 
sites.7,8,9 Recently, a new de novo DNA methyltransferase, DNMT3c, was 
discovered in rodent genomes, and it was shown to  methylate the promoters 
[G] of evolutionarily young retrotransposons in the male germ line.10 
 
In mammals, DNA methylation is involved in the maintenance of cellular 
functions and genomic stability, including processes such as X chromosome 
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inactivation, genomic imprinting [G] and transposon silencing [G].11,12,13,14 
Importantly, DNA methylation, does not function in isolation, but  works in 
conjunction with histone modifications [G] within specific chromatin contexts. 
Indeed, it is becoming clear that epigenetic crosstalk exists between DNA 
marks and key chromatin components; this crosstalk involves various 
chromatin-remodeling proteins [G].15  
 
 Cytosine methylation predominantly occurs within the C-G dinucleotide 
(which is often referred to as cytosine-phosphate-guanine (CpG)) outside 
CpG islands (CGI) [G].13 Recent studies, in which defined DNA sequences 
were inserted into the same locus of the genome, suggest that the overall 
base sequence composition influences DNA methylation and histone 
modifications at some CpGs but not at others.16,17 These studies support the 
view that the genome shapes its epigenome, although the mechanism 
underlying how sequence composition imparts methylation status is still not 
understood.  
 
 During early mammalian development, DNA methylation changes 
throughout the genome to direct pluripotent stem cells [G] to differentiate into 
distinct lineages that form various tissue types. Passive demethylation occurs 
when the DNA in newly replicated cells is not remethylated. DNMT1 is thought 
to exhibit a preference towards hemi-methylated sites over hemi-
hydroxymethylated sites, thereby inhibiting 5mC maintenance18. Active DNA 
demethylation (that is, enzyme-mediated DNA demethylation) has also been 
observed, for example within the enhancer regions [G] of developmental 
genes during the phylotypic period (that is, during the development of the 
basic body shape) in organisms including mouse.19 The active demethylation 
pathway involves the iterative oxidation of 5mC to 5-hydroxymethylcytosine 
(5hmC), 5-formylcytosine (5fC) and 5-carboxycytosine (5caC) by the ten-
eleven translocation (TET) enzymes (namely, TET1, TET2 and TET3), which 
are 2-oxoglutarate (2-OG) and Fe(II)-dependent dioxygenases. Subsequently, 
5fC or 5caC is removed by base excision repair [G] (BER), which is mediated 
by the thymine DNA glycosylase (TDG), and replaced by unmodified cytosine 
(FIG. 3).20 The loss of function of enzymes, including TET and TDG, 
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compromises the differentiation of mouse embryonic stem (mES) cells and is 
embryonically lethal in mice, illustrating that this DNA metabolism is vital to 
mammalian development.21,22  
 
Although global levels of 5fC in mES cells (0.02% / dG, as measured 
by liquid chromatography coupled to tandem mass spectrometry (LC–MS/MS) 
(See Box 2)) are lower than that of 5hmC, 5fC was found to occur at 
comparable levels to 5-hmC at specific genomic loci.23,24,25 Recent 
developments that exploit chemistries for resolving DNA modifications, 
together with high-throughput (sometimes called ‘next generation’) 
sequencing approaches, have allowed the genome-wide mapping of 5hmC, 
5fC and 5caC (see Box1 and Table 1). 5hmC, 5fC and 5caC are enriched in 
poised and active enhancers in ES cells and in mouse embryonic 
tissues.26,27,28 Enhancers are distal regulating elements that initiate 
transcription by delivering protein complexes to promoters. Poised enhancers 
(that is, enhancers that are inactive but ready for activation) are flanked by 
bivalent histone marks (that is, histone modifications that combine the 
activating mark histone H3 lysine 4 monomethylation (H3K4me1) and the 
repressive mark histone H3 lysine 27 trimethylation (H3K27me3)), whereas 
active enhancers are marked by histone H3 lysine 27 acetylation (H3K27ac) 
and H3K4me1. Although oxidized cytosine derivatives were initially regarded 
as intermediates on the pathway to demethylation (FIG. 3), it is emerging that 
they may function as epigenetic marks in their own right. Indeed, isotopic 
labeling experiments have shown that 5hmC and 5fC are largely stable in the 
genomic DNA of cultured cells and in vivo.29,30 Additionally, 5hmC, 5fC and 
5caC-specific binding proteins have been identified from proteomics 
experiments that support roles for these cytosine modifications in chromatin 
remodeling and transcriptional regulation.31,32,33 Another study found that 
double stranded 5fC-containing DNA could covalently interact with DNMT1; 
the bond formed between the 6C of 5fC and a catalytically essential cysteine 
residue of DNMT1 in vitro.34  
Since chromatin is key to all DNA-related processes (that is, 
replication, recombination, transcription, repair and chromosome 
segregation), it is essential to comprehend how DNA modifications effect the 
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regulation and dynamics of chromatin structure to elucidate their biological 
function. Several groups have analysed the effect of cytosine modifications 
within CpG repeats on the stability of the DNA double helix.35,36 5mC and 
5hmC, but not 5fC and 5caC, were found to stabilize the DNA duplex. 
Additional biophysical experiments and X-ray crystallography on 5fC-
containing oligonucleotides showed that 5fC can alter the structure of the 
DNA double helix through an extensive hydration network, suggesting that 
5fC may be involved in chromatin remodeling by causing a change in DNA 
conformation.36 In contrast to this work, a recent study36b reported no 
significant alteration of the structure of DNA containing 5fC, which may reflect 
a capacity for 5fC-DNA to dynamically interconvert between structures. 
Indeed, a recent molecular dynamics simulation study demonstrated that 5fC 
and 5hmC enhance the flexibility of the DNA double helix, whereas 5mC 
reduces DNA flexibility.37 The increase in the flexibility of DNA caused by 5fC 
and 5hmC increased the mechanical stability of nucleosomes (that is, the 
basic packaging unit of DNA in eukaryotes), indicating that these 
modifications may influence the dynamics of chromatin structure in vivo.  
The direct effects of cytosine modifications on the structure of 
nucleosomes have been studied using single molecule Förster resonance 
energy transfer (FRET) analysis. It was reported that CpG methylation 
resulted in DNA that was more tightly wrapped around the histone octamer 
[G], suggesting that CpG methylation may contribute to the formation of a 
repressive chromatin state.38,39,40 5hmC-containing DNA also displayed an 
increased binding affinity for the histone octamer, although a weakened 
interaction between hydroxymethylated DNA and the H2A-H2B dimer subunit 
was also observed.  
 
Finally, a nucleosome reconstitution experiment using methylated and 
unmethylated genomic DNA from two cell lines investigated the effects of 
DNA methylation on the positioning and stability of nucleosomes.41 This study 
showed that the DNMT-mediated methylation of CpG dinucleotides in vitro 
changed the nucleosomal organization. Specifically, unmethylated CpG 
islands near transcription start sites became enriched in nucleosomes upon 
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their methylation, suggesting that the impact of DNA methylation on 
nucleosome positioning in vitro can reflect in vivo states. 
 
Thymine modifications. 
DNA generally contains T as the cognate base to A, rather than uracil 
(U); U is present in RNA. However, studies using ultra high performance liquid 
chromatography coupled to tandem mass spectrometry (MS/MS) (UHPLC-
MS/MS) demonstrated that the nucleoside 2’-deoxyuridine (dU), which lacks a 
methyl group at the C5 position of the base, is present at low levels in DNA42. 
A large variance in reported levels of dU in DNA is likely to be an artifact 
caused by deamination during DNA digestion or extraction. dU may arise due 
to the aberrant incorporation of 2’-deoxy-uridine-5’-triphosphate (dUTP) or it 
can be formed by spontaneous or enzyme-mediated hydrolytic cytosine 
deamination, resulting in a U:G mispair.43 Several uracil DNA glycosylase 
repair enzymes can remove uracil from DNA via the BER pathway. The main 
candidates are the uracil DNA glycosylase (UDG) enzymes, although single 
monofunctional uracil glycosylase 1 (SMUG1) is thought to be a ‘back-up’ 
enzyme and TDG and methyl binding domain-4 (MBD4) can also excise dU, 
particularly when it is present as U:G mispairs.43 
 
Although spontaneous hydrolytic deamination is slow, cytosine deamination 
can be driven enzymatically by the cytidine deaminases, activation-induced 
cytidine deaminase (AID) and apolipoprotein B mRNA-editing enzyme, 
catalytic polypeptide-like (APOBEC). They belong to the same family of 
enzymes, the cytidine deaminases, which is thought to have unique roles for 
generating specific genetic mutations and C-to-T transitions.44 AID-mediated 
deamination in the immunoglobulin genes of B cells [G] provides an essential 
mechanism for somatic hypermutation and class-switch recombination [G] of 
DNA, leading to antibody diversification as part of the immune response. 
There is also some speculation that U may be an intermediate in the active 
demethylation of 5mC. 45 Indeed, AID is involved in a TET-independent active 
demethylation process at promoter regions. However, although AID can 
deaminate 5mC directly, alternative hypotheses suggest that the AID-driven 
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deamination of C to U could initiate BER of 5mC containing sequences, 
leading to overall demethylation.  
 
Eukaryotic DNA contains oxidised thymine derivatives, which are 
analogous in structure to those observed for cytosine modifications. 5-
Hydroxymethyluridine (5hmU) and 5-formyluridine (5fU) occur at a level of 
0.00001-0.0001%/dN in mammalian DNA.46 Both modifications have been 
traditionally considered to be oxidative lesions caused by radical oxidation of 
thymine. Both 5hmU and 5fU can be excised by SMUG1 when base-paired 
with A47, yet they are repaired by several DNA glycosylases, including TDG 
and MBD4 when mispaired with G; the pairing of 5hmU and 5fU with G can 
occur as a consequence of deamination of the corresponding C-derivative.48  
 
 As well as being the result of oxidative DNA damage, 5hmU may have 
a functional role in mammalian DNA. For example, some evidence suggests 
that 5hmU is an intermediate of active demethylation intermediate, formed 
from the deamination of 5hmC by AID and APOBEC enzymes. However, 
whereas one study provided evidence to suggest that AID and APOBEC 
facilitated the deamination of hmC 49, others found such enzymes had little 
ability to deaminate this modification in vitro50.  
To determine the origin of T modifications in mammals, mES cells were 
grown in the presence of isotopically labeled thymine and methionine, and 
subsequently analysed by LC-MS/MS (Box 2).46 Whereas all 5hmU and 5fU 
bases were found to be derived from isotopically labeled thymidine in wild-
type cells, ~7% of 5hmU was found to be derived from 5hmC in cells in which 
TDG had been knocked down. This indicates that a 5hmC deamination 
pathway may occur, but that 5hmU resulting from this pathway is rapidly 
repaired.  
 
Two independent groups have shown that 5hmU can be generated 
enzymatically from thymine oxidation46,51 by the TET family of oxidase 
enzymes. 5hmU levels correlated with TET expression, and subsequent 
differentiation studies showed that 5hmU appeared to form in processes that 
also lead to the production of 5hmC and 5fC. Proteomics studies have shown 
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5hmU to be recognized by chromatin remodeling proteins and transcription 
factors, suggesting a potential role for it in gene regulation.46  
 
T modifications are also prominently observed in the genomes of 
trypanosomatids [G].52,53,54 For instance, the hypermodified glucosylated 
thymine, β-D-glucosyl-hydroxymethyluracil, which is  known as Base J (FIG. 
2), exists in trypanosomatid species (0.5% J/dT in Trypanosome brucei) as do 
5hmU and 5fU (0.04% hmU/dT, 0.08% fU/dT Trypanosome brucei). Within 
trypanosomatids, thymine is enzymatically oxidised to 5hmU by the J-binding 
proteins (JBP)55, which are Fe(II) and 2-OG dependent dioxygenases 
homologous to the TET enzymes in mammals. JBP1 is thought to maintain T-
modifications, whereas JBP2 is thought to regulate the generation of de novo 
5hmU biosynthesis. 5hmU is subsequently subject to β-glucosylation by the J-
glucosyltransferase (J-GT) enzyme, which results in the production of Base 
J.53  Base J exists mainly in telomeric regions [G] or repetitive elements [G] of 
DNA, and is enriched at sites of RNA polymerase II [G] initiation and 
termination, consistent with a role for Base J in transcriptional regulation. 
Depletion of Base J from various trypanosomatids caused increased ‘read-
through’ at transcriptional termination sites or termination defects, leading to 
altered expression of downstream genes and indicating a direct link between 
Base J and transcriptional regulation.56,57 Base J loci are also associated with 
modified histone H3 variants58 in certain trypanosomes, providing further 
evidence of epigenetic crosstalk between DNA and histones in chromatin. 
 
Adenosine modifications: N6-methyladenosine  
 
N6-methyladenosine (6mA) is an adenosine modification that has long 
been known to exist in the genomes of prokaryotic organisms. By contrast 
with the DNA modifications discussed so far, 6mA can interfere with Watson–
Crick base pairing when the methyl group is in its preferred cis conformation 
(see FIG. 2). However, the methyl group rotates into the less-favoured trans 
position when in double stranded DNA, meaning that 6mA destabilizes DNA 
as compared to A due to the energetic penalty.59 6mA in prokaryotes confers 
resistance against a host immune response as it cannot be broken down by 
 10 
host endonucleases; however 6mA can also modulate transcription in some 
bacteria.60  
6mA is also present in the genomes of simple eukaryotes, such as the 
green algae Chlamydomonas61, and there has been a resurgence of interest 
in 6mA owing to its identification in a number of higher eukaryotic organisms. 
Specifically, 6mA has been identified in Caenorhabditis elegans (nematode 
worms)62, Drosophila melanogaster (fruit flies)63 and mammals and 
vertebrates64,65, where it is implicated in development. 
Further study of 6mA in these species suggests that the role of this 
mark varies between organisms. 6mA in green algae (0.4% 6mA/dA) 
appeared to be associated with active gene expression and was found to be 
highly enriched in linker DNA, suggesting a role in nucleosome positioning66. 
Work with C. elegans (0.3% 6mA/dA) indicates that epigenetic crosstalk 
occurs between 6mA and histone methylation, with evidence suggesting that 
the 6mA mark could be inherited across generations. 62 
In D. melanogaster, 6mA levels were higher in early embryogenesis 
(0.07% 6mA/dA) to than at later stages of development (0.0001% 6mA/dA). 
Furthermore, overexpressing an identified DNA 6mA demethylase (DMAD-1) 
in D. melanogaster was lethal to flies in early development, supporting a 
requirement for 6mA in genomic DNA during D. melanogaster development. 
63 
6mA was recently reported in vertebrates and mammals, albeit at low 
levels (0.00009% 6mA/dA in Xenopus laevis (frogs)64, ~0.0006% 6mA/dA in 
mouse65). Work with mES cells found that the presence of 6mA led to 
transcriptional silencing.65 Furthermore this study revealed that 6mA was 
mainly enriched on the X chromosome and a putative demethylase (ALKBH1) 
has been identified; knockdown of the gene encoding this protein in mES cells 
led to elevated levels of 6mA and the downregulation of >500 genes. 
However, ALKBH1 is also known to function as a m1A demethylase67 and 5-
mC dioxygenase in transfer RNA [G] ,which might be important for regulating 
translational 68, and it has also been shown to possess lyase activity at abasic 
sites51.  
A link between 6mA and early embryogenesis was also demonstrated 
in zebrafish and pigs by LC-MS/MS, as 6mA were observed to reach levels as 
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high as 0.1% 6mA/dA in early embryonic stages, before being drastically 
reduced.69 This highlights a potential role for 6mA in early mammalian 
development, which is in line with a role for 6mA in the development of D. 
melanogaster.  
It should be noted that one LCMS/MS study could not replicate the 
levels of 6mA observed by others in mESC and mouse tissues, cautioning 
that the presence of 6mA in other studies may have arisen as an artifact due 
to bacterial contamination.70 This has raised questions over the potential 
relevance of 6mA in mammalian DNA, and further work is needed to confirm 
such studies. The study doesn’t explore early embryonic samples in which 
6mA levels are reported to be substantially higher.  
Over the recent years it has become apparent that eukaryotic genomes 
contain various DNA modifications. Technical advances have allowed us to 
detect, quantify and determine their genomic loci. The chemistry associated 
with these technologies is discussed in the next section. 
 
Chemistry-based sequencing methods  
Chemistry has played a central role in the development of innovative 
tools that contribute to the understanding of the function of modified DNA 
bases. Herein, we focus on chemical approaches for the detection, mapping 
and sequencing of modified DNA bases in the genomes of various organisms 
(TABLE 1).71  
 
General sequencing approaches to detect modified bases.  
The known modified bases preserve the Watson–Crick base-pairing 
pattern of canonical bases and consequently cannot be detected or decoded 
by the most widely used sequencing approaches that read the Watson–Crick 
primary sequence code. Progress has been made in utilizing single-molecule 
real-time sequencing (SMRT-seq) (see below), which relies on monitoring 
single-molecules during real-time temporal fluctuations as a polymerase 
incorporates nucleotides directed by template DNA. The DNA modifications in 
the template can lead to a characteristic ‘signature’ during DNA synthesis, 
although this approach remains challenging for large genomes such as 
humans. The nanopore sequencing approach (see below) also has the 
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potential to differentiate modified bases when decoding DNA and may well 
have broad potential in due course. A practical and general approach to 
detecting natural DNA modifications in large genomes (such as the human 
genome), is to enrich DNA fragments that contain the modified base of 
interest, before DNA sequencing. This can be done by chemically tagging the 
modified base with an affinity tag, such as biotin (FIG. 4), followed by 
enrichment of the tagged base with streptavidin magnetic beads that bind to 
biotin. Alternatively, affinity enrichment can be carried out using antibodies 
that are specific for the DNA modification of interest. High throughout 
sequencing of the enriched fragments results in a build-up of ‘reads’ at certain 
genomic locations that reveals where such modifications occur in the genome 
(BOX 1). 
 
Specific restriction endonucleases, coupled with sequencing, can also be 
utilized to detect the sites of modified bases. Restriction enzymes cleave the 
phosphodiester backbone of DNA at a particular sequence, and differentially 
cut at the site depending on the presence or absence of a modification. The 
enzyme AbasI, for example, is used for the sequencing of 5hmC sites.72 
AbasI preferentially cuts glucosylated 5hmC (5ghmC) and generates cleavage 
sites with DNA overhangs. Biotinylated adapters containing randomized 
sequences are then used to hybridize to the cleavage sites and pullout and 
sequence 5hmC sites. Although this approach provides a simple and cost 
effective way of detecting modified bases, target sites are cleaved with 
varying efficiency.73  
 
 
Detecting modified bases at single-base resolution using bisulfite.  
To determine the presence of a modified base at single-base 
resolution, methods that cause a selective chemical transformation that alters 
the Watson–Crick base-pairing pattern, such as the bisulfite reaction, can be 
broadly applied to established sequencing platforms. The bisulfite reaction, 
which decodes the cytosine modification 5mC, catalyses the hydrolytic 
deamination of cytosine to uracil, whilst 5mC remains resistant to deamination 
(FIG. 4).74 Since U has the same base-pairing properties as T, the resultant U 
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base pairs with A rather than G. The bisulfite-mediated conversion of DNA 
followed by sequencing, which is referred to as bisulfite-sequencing (BS-seq), 
creates a global genome-wide map at single-base resolution on which C and 
5mC can be distinguished. A drawback of BS-seq is that it cannot distinguish 
between 5mC and 5hmC, since both are resistant to deamination75 and 
cytosine, 5fC and 5caC all convert to uracil under bisulfite conditions.  
 
Chemical and enzymatic methods have been developed to distinguish 5hmC 
from 5mC (FIG. 4 and TABLE 1). Oxidative bisulfite sequencing (oxBS-seq)76 
uses potassium perruthenate (KRuO4) to first selectively oxidize 5hmC to 5fC, 
which deaminates to uracil along with  C and 5caC during subsequent bisulfite 
treatment. This means that, in oxBS-seq, only 5mC is read as “C”, giving a 
direct readout of this C modification. Subtracting an oxBS-seq dataset from a 
BS-seq dataset of the same DNA sample can reveal the presence of 5hmC at 
single base resolution.  
 
Chemo-enzymatic TET-assisted bisulfite sequencing (TAB-seq)77 provides 
another method to resolve 5mC and 5hmC at single-base resolution. 5hmC is 
first protected by glucosylation using a T4 β-glucosyltransferase (β-GT). 
Recombinant mouse TET1 (mTET1) is then used for the iterative oxidation of 
5mC to 5caC, which deaminates to uracil during subsequent bisulfite 
treatment. As glucosylated 5hmC is the only remaining C-derivative that does 
not deaminate, TAB-seq can give a direct readout of 5hmC. Subtracting a 
TAB-seq dataset from a BS-seq dataset for the same DNA sample reveals 
where 5mC is present in the genome at single base resolution.  
 
Other methods have since been developed for the sequencing of modified C 
bases (FIG. 4 and TABLE1).71 Reductive bisulfite sequencing (redBS-seq), for 
example, uses NaBH4 to reduce 5fC to 5hmC.24 Similar to the procedure for 
oxBS-seq, subtraction of the redBS-seq dataset from a BS-seq dataset allows 
the single base resolution sequencing of 5fC. Another bisulfite-based method 
exploits the use of chemical treatment with EtONH2, which protects 5fC from 
bisulfite-mediated deamination; this method is called 5fC chemically assisted 
bisulfite sequencing. (fCAB-seq)78. Comparing the fCAB-seq dataset with the 
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BS-seq dataset allows the genomic location of 5fC to be determined at single 
base resolution.  
While bisulfite based sequencing is regarded as the ‘gold standard’ for 
the analysis of C modifications, it has serious deficiencies. Bisulfite treatment 
induces the loss of pyrimidine bases from the DNA strand, which 
subsequently facilitates strand cleavage via β -elimination [G] and δ -
elimination [G] of up to 99% of the original DNA.79 Several rounds of 
amplification by polymerase chain reaction (PCR) are therefore required to 
generate enough DNA for sequencing. While the amplification by PCR is a 
fundamental step, especially when working with low amounts of DNA, it may 
introduce PCR biases. Two independent approaches have addressed this 
issue by developing amplification-free bisulfite sequencing methods called 
recovery after bisulfite treatment (ReBUiLT)80 and post-bisulfite adaptor 
tagging (PBAT)81. These methods result in increased uniformity of coverage 
and an adapted version of the latter technique is now the standard method for 
analyzing DNA methylation in single cells.82 In this adaptation of PBAT, 
bisulfite conversion is performed on single cells prior to five rounds of random 
priming to tag and amplify the material.  
 
Bisulfite-free techniques to detect modified bases at single-base resolution  
Bisulfite-free base resolution sequencing methods have recently been 
developed that enable C-to-T transitions during PCR. One such technique 
takes advantage of the conversion of hmC to trihydroxylated thymine using 
peroxotungstate83, whereas another, 5fC cyclization-enabled C-to-T transition 
(fC-CET) sequencing, selectively targets 5fC using derivatives of 1,3-
indianone 84 (FIG. 4 and TABLE 1).  
 
Modified bases can also be detected at single-base resolution, without any 
prior chemical transformation, using SMRT-seq.85 In this single-molecule 
sequencing technology, fluorescent nucleosides, each of which has a unique 
kinetic signature, are inserted opposite the template strand by a processing 
polymerase. Modified bases in the template strand can be differentiated from 
canonical bases as the polymerase has a greater tendency to pause in the 
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presence of a modification. Chemical labeling is commonly used in 
combination with SMRT-seq to improve signal detection, as bulkier modified 
bases are easier to distinguish from canonical bases.86 Simultaneous 
mapping of 5hmC, 5fC and 5caC was achieved using chemical labeling and 
SMRT-seq at near single base resolution in a fungal model system.87 SMRT-
seq can readily detect Base J88 and 6mA65 at single-base resolution without 
the necessity of chemical tagging. Finally, as well as not requiring the DNA to 
be chemically transformed, SMRT-seq also enables longer reads (up to 
20,000 bp) compared to Illumina sequencing. However, this sequencing 
method still has reasonably low throughput, meaning it is only feasible for 
detecting modified bases in smaller genomes or in larger genomes after 
enrichment. 
 
Another emerging single molecule sequencing technique that does not require 
chemical or enzymatic transformation or amplification is nanopore 
sequencing. This technique measures the current as each nucleobase travels 
through a nanopore electrophoretically. This technology has been 
successfully used to sequence small viral and microbial genomes and, more 
recently, to map and quantify 5mC and 5hmC in synthetic and genomic 
DNA.89,90,91,92,93,94 Improvement in this technology now allows the detection of 
5mC in the human genome with 82% accuracy92 and we anticipate that 
nanopore sequencing instruments may be used more routinely in the future.  
 
DNA modifications in disease and therapy  
It is emerging that DNA modifications not only play fundamental roles during 
normal development, but also may contribute to disease progression. 
Ultimately, understanding and control over these processes may lead to novel 
therapeutic approaches as outlined in the next section. 
 
DNA base modifications in disease.  
The epigenetic profile of a genome reflects its cellular state and can 
reflect the identity of the cell or tissue. In an evolving cancer genome, the 
epigenetic state of DNA bases is thought to influence the mutational changes 
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that occur, such that the mutation rate variation is linked to the epigenomic 
features of the cell of origin.95,96,97  
 
Two independent studies have reported, for example, that 5mC is more 
likely than 5hmC to undergo C-to-T changes in the context of CpG in human 
malignancies.98,99 Also, in disease states, epigenetic marks can become 
aberrant and methods to detect such changes have the potential to detect, 
diagnose and monitor disease. For example, atypical methylation patterns at 
specific CpG islands and in tumor suppressor genes is a hallmark of 
cancer.100,101,102 In addition, certain genes are hypermethylated in a number of 
neurodegenerative disorders, including Alzheimer’s disease.103  
 
A global reduction in 5hmC levels has been observed in many cancers. This 
reduction may arise from mutations that result in dysfunctional TET proteins; 
the increased production of the TET inhibiting metabolite 2-hydroxygluturate, 
which can be caused by mutations in the genes encoding enzymes such as 
isocitrate dehydrogenase (IDH)); or the silencing of TET proteins as a result of 
methylation of the genes that encode them.104,105,106,98 Alternatively, TET-
mediated 5hmC simply may not be maintained in cancerous tissue as there is 
a correlation between 5hmC levels and cell proliferation, i. e. 5hmC is 
passively diluted out of the genome.29 Although global epigenetic changes 
might be indicative of disease, clinical case studies that identify specific 
epigenetic changes that mark, or more preferably indicate the cause of, the 
disease state may lead to clinical tests. Indeed, a 5mC based diagnostic test 
was recently approved for the non-invasive detection of colorectal cancer, 
which paves the way for other epigenetics-based diagnostic tests in the 
future.107 Also routinely used in the diagnosis of glioblastoma is a test that 
measures the level of methylation at the promoter of the O6-methylguanine–
DNA methyltransferase (MGMT) gene. MGMT is involved in the repair of 
alkylating agent-induced damage in DNA and methylation of the MGMT 
promoter decreases the expression of MGMT protein and, therefore, 
potentially increases the sensitivity of patients with glioblastoma to therapy.108  
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There is also a potential link between T modifications and disease in 
mammalian systems. 5fU is a known mutagen in mammalian tissue, likely due 
to its propensity to mispair with guanine in DNA109, and elevated blood levels 
of 5hmU have been linked with breast and renal cancer.110,111 Levels of uracil 
are reported to be elevated in cancerous tissue, and enzymatic deamination 
that is mediated by AID and APOBEC is thought to cause C-to-T transitions in 
tumour suppressor genes or oncogenes and to be linked with the onset of 
disease.112 These cytidine deaminases are overexpressed in certain cancers, 
although there is currently some debate as to whether the mutations they 
cause are derived from the deamination of cytosine, or of 5mC, or of both.113 
AID overexpression is associated with global demethylation, with mutational 
biases located at CpG sites, although AID enzymes demonstrate greater 
activity towards unmethylated cytosine in vitro.50  
 
Therapeutic approaches for targeting DNA base modifications in disease.  
Due to the link between aberrant epigenetic regulation and disease, it 
is attractive to consider therapeutics that can reprogramme the epigenome of 
cells towards a non-disease state. Inhibitors of DNA methylation can reduce 
methylation and increase the expression of certain genes in disease states. 
For example, the ribo- and deoxyribonucleoside analogues of 5-azacytidine 
are currently used in the clinic to treat cancer including leukemia.114 They are 
thought to become phosphorylated on three sites before being incorporated 
into genomic DNA during replicative DNA synthesis. In 5-azacytidine the ring 
carbon C5 is replaced by a nitrogen, after attack of the DNMT’s cysteine at 
C6, the enzyme is not released causing the formation of an irreversible 
covalent adduct with, and the inhibition of DNMT enzymes; this inhibition 
results in the global loss of cytosine methylation, in addition to some DNA 
damage response. For cancers that exhibit loss of 5hmC due to mutations in 
the gene encoding IDH, inhibitors of aberrant IDH are currently in clinical 
trials115 with the aim of alleviating the inhibition of TET activity to restore a 
healthy epigenome.  
 
Inhibitor based approaches that cause global epigenetic reprogramming could 
be cytotoxic as it might affect the expression of many genes. Approaches for 
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editing the epigenome at specific sites are therefore also being explored. For 
example, minor-groove polyamides have been shown to specifically target 
CpG sequences, leading to the inhibition of DNMTs at this particular 
sequence.116 Clustered regularly interspaced short palindromic repeats 
(CRISPR) systems [G] or transcription-activator like effectors (TALEs) [G] 
that have been tethered with DNA modifiers such as DNMT and TET have 
also been shown to specifically alter gene expression, highlighting a potential 
approach for future therapy.117,118 
 
There are also opportunities to develop epigenetic therapies that target the 
unique regulatory system used in trypanosomatids. Inhibitors could be 
developed to specifically target JBP or JGT enzymes; targeting these 
enzymes would globally deplete Base J, which affects transcriptional 
regulation in these systems. Such therapeutics could be useful to treat a host 
of tropical diseases that are associated with trypanosomatids, such as 
Leishmaniasis and African sleeping sickness,119 potentially without side-
effects as these enzymes are absent in humans.  
 
Concluding remarks and future outlook 
The discovery and subsequent insights gained into oxidised cytosine 
modifications in the human genome has stimulated considerable interest in 
the chemical modification of nucleotides. The discovery of 5hmC in 
mammalian DNA was partly inspired by knowledge of the homology between 
JBP enzymes in trypanosomatids and the mammalian TET enzymes.120,121 
The growing knowledge of known DNA base modifications and the huge 
expansion in our knowledge of genomes and genome function provides 
information and inspiration for other exciting discoveries in due course.  
State-of-the-art chemical analysis techniques, such as LC-MS/MS, now 
allows the abundance and formation of relatively rare base modifications, 
such as 5hmU, to be identified as veritable DNA modifications rather than 
ubiquitous damage in mammals. In the future, the sensitivity of such methods 
will improve and will enable us to uncover more about other chemical 
modifications in the genome. It will be important to confirm that observed 
modifications, especially rare ones, are natural to the genome and rule out the 
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possibility of artifacts and background contamination. The use of stable 
isotope tracing experiments in combination with mass spectrometry can help 
with this and can also provide an understanding of the metabolism and 
dynamics of DNA base modifications. Understanding the enzymology 
associated with DNA modifications will be essential in elucidating their roles in 
biology. Ultimately, sequencing all modified bases in a single experiment, 
preferably at the single cell level, is a desirable goal and also a major 
technical challenge. The exploitation of the natural chemo-physical 
characteristics of base modifications in single molecule approaches such as 
SMRT-seq and nanopore sequencing is an attractive possibility to consider in 
the future. DNA comprises a wide, natural and dynamic chemical repertoire 
that encodes information in living systems. Further advances in chemical 
methodologies can help drive a more complete understanding of how and why 
the chemistry of DNA can reprogramme the biology of cells and organisms. 
 
Box 1 Figure:  
 
Box 2 Figure:   
 
BOX 1: Mapping modified DNA bases using DNA 
immunoprecipitation followed by high throughput sequencing.  
To prepare DNA for sequencing, it is first fragmented by sonication or broken-
down into smaller fragments of around 250 bp (see the figure, step 1). These 
DNA fragments then undergo a ‘library preparation’ procedure, which involves 
the ligation of DNA sequencing adaptors to them using a DNA ligase (see the 
figure, step 2). DNA fragments can then either be directly hybridized onto the 
flow cell and bridge amplified for the enhancement of the fluorescent signal 
(see the figure, arrow pointing down, step 3a) or first enriched for 
the desired DNA modification (see the figure, arrow pointing to the right, step 
3b) followed by hybridization and amplification. 122,123 Complementary dNTPs, 
which are labeled with a specific fluorophore124,125, are inserted opposite the 
template strand via Watson–Crick base pairing by a DNA polymerase (see the 
figure, step 4). Protecting groups present on the 3’-OH group of each 
nucleoside control the incorporation to a single nucleotide. After each 
 20 
nucleotide is incorporated, the fluorophore is read by imaging (see the figure, 
step 5) to reveal the identity of the base. Subsequent deprotection of the 3’-
OH protecting group and removal of the fluorescent label via Staudinger 
reduction chemistry allows the cycle to be repeated. This process leads to 
build up of sequences that are obtained, known as ‘reads’, and can be 
bioinformatically aligned to the reference genome of any organism.  
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Box 2| LC-MS/MS based methods for the global quantitation of modified 
bases.  
Quantitative detection of modified DNA bases is a powerful tool for the 
discovery and elucidation of such modification in the genomes of organisms. 
29,52,46,23,126,127 Liquid chromatography-tandem mass spectrometry (LC-
MS/MS) is a chemically discriminating method of nucleotide analysis that is 
used for quantitatively detecting modified and canonical nucleosides directly 
from digested samples of DNA (see the figure, part a). During LC-MS/MS, 
genomic DNA is digested into mononucleosides that are subsequently 
separated by their polarity via liquid chromatography before injection into the 
mass spectrometer. The unique mass of the parent modified base ion is 
measured, allowing the accurate mass of nucleoside fragments to be 
extracted from the total ion count (TIC). This gives a definitive mass signal 
that is unique to a particular modified base and that can be accurately 
integrated for quantification. The integration of the mass signal is then 
compared to the linear fit equation from calibration curves of synthetic 
standards to determine the concentration of modified base in each sample. 
The gold-standard of mass quantification employs an internal standard that is 
isotopically labelled (SIL) to enable robust and accurate quantitation of DNA 
modifications typically at femtomole quantities.128 (see the figure, part 
b).  Ideally the SIL has chromatographic and ionisation properties that are 
virtually the same as the non-labelled analyte but a different mass signal that 
can be integrated separately (for example, 13CD3 is used to label 5mC; 15N3 is 
used to measure dC, note 13C and 15N isotopes are annotated with blue 
asterisks) The amount of isotope-labeled internal standard is added to the 
calibration line and to each digested sample in equal amounts. The area ratio 
between the labeled and non-labeled base can then be used for improved 
precision in the quantificationThe SIL standard and analyte itself will co-elute, 
correcting for matrix effects, and will also account for variation in injection 
volume or ion suppression.  
Modern-day mass spectrometers can accurately quantify over a wide-range of 
concentrations and are sensitive enough to detect femtomol (fmol) levels of 
(modified) nucleosides.46 Mass signals can be improved by HPLC or affinity  
pre-enrichment (for example, biotin can be used to concentrate sample by 
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affinity enrichment prior to injection of large quantities of digested DNA prior to 
LC-MS/MS injection52,23, or via the prior chemical derivatization of modified 
bases with a MS sensitizer tag containing for example a quartenary 
nitrogen.129 This has been applied for the detection of low abundance 
modifications (< 0.001% of bases) such as 5fC23 and 5fU129 by hydrazone 
formation with such a MS sensitizer. LC-MS/MS has been used to look at the 
difference in modifications between different organisms, tissues, cancer-
states and ages of tissue.130,131,132 Quantification of modified bases can also 
be used to determine or validate the effect of depletion or overexpression of 
certain modifying enzymes.63,46 
LC-MS/MS can also be used to look at the lifetime, origin and 
dynamics of DNA modifications via the use of metabolic isotopic labeling (see 
the figure, part c). The C modifications can be traced via the feeding of cells 
and mouse models with 13CD3 methionine. The SIL labeled methionine is 
converted to the methyl donor S-adenosyl-[13CD3]-methionine (SAM) and 
through catalysis of the DNMT enzyme, leads to the formation of +4 
isotopically-labelled 5-methylcytidine. As a result, the oxidative derivatives, 
that is, 5hmC and 5fC29,30 will also become SIL labeled as depicted in figure 
panel c. Other modified bases have also been studied by this type of isotope 
tracing experiments. For example, the formation of 5hmU has been discerned 
by feeding combinations of stable isotope labeled methionine and a labeled 
thymidine.46 
 
 
 
 
 
 
 
 
Figure 1: Watson and Crick base pairing and DNA grooves.  
A) The primary genetic code comprises the nucleobases adenine (A), guanine 
(G), cytosine (C) and thymine (T). Deoxyguanosine (dG) pairs with 
deoxycytidine (dC), and deoxyadenosine (dA) pairs with deoxythymidine (dT), 
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in an anti-parallel arrangement to form a secondary structure. B) The major 
and minor grooves of the AT, TA, CG and GC base pairs are shown. Arrows 
indicate hydrogen donors (purple arrows) and hydrogen acceptors (cyan 
arrows), note how this pattern changes between the major but not the minor 
grooves of AT versus TA and CG versus GC. C) On top of the primary and 
secondary code (major groove) lies the epigenetic code, which has additional 
functionality and is depicted here by methylation pointing out into the major 
groove.  
 
Figure 2: A) Overview of modified DNA bases. The four canonical bases 
are depicted, with the sites of known modification shown in red font or circled. 
B) Chemical space of the modified DNA bases that have been reported in the 
literature. Names represent the bases depicted, R indicates 2’-deoxy-D-ribose 
and names in a box are modifications that have been identified in eukaryotic 
genomes and are discussed in the scope of this Review; other modifications 
have been reviewed elsewhere5 *More complex branching of mixtures with up 
to three furanose residues (Glc and Gal) have also been reported. ** The 
precise distribution of the two substituents over the 4- and 5-hydroxyl groups 
has not been determined. Note that 6mA is shown with the N6-Me group in its 
energetically preferred cis conformation. 
 
Figure 3: The active demethylation pathway. In eukaryotes, methylation at 
the C5 position of cytosine (C) is catalyzed by DNA methyltransferases 
(DNMTs), which use S-adenosylmethionine (SAM) as the methyl donor, to 
result in the formation of 5mC (orange arrow). The postulated active 
demethylation pathway involves the iterative oxidation of 5mC to 5-
hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-carboxycytosine 
(5caC) via TET enzymes (pink arrows). 5fC and 5caC then can be excised by 
thymine DNA glycosylase (TDG, green arrows) to form an apyrimidinic (AP) 
sites that further undergoes base excision repair (BER, yellow arrow) 
subsequently reinstalls the cytosine.  
 
Figure 4| Methods for the sequencing modified C bases. A) Bisulfite 
induced deamination of cytosine to uracil changes the base-pairing and is the 
 24 
underlying principle of bisulfite sequencing B) Oxidative bisulfite sequencing 
(OxBS),  Reductive bisulfite sequencing (RedBS) and TET-assisted bisulfite 
(TAB) sequencing add an additional chemical or enzymatic step prior to 
bisulfite treatment, which enables the discrimination between mC, hmC and 
fC at single base resolution C) fC-CET (5fC cyclization-enabled C-to-T 
transition)  is a bisulfite-free sequencing method that relies on the selective 
chemical manipulation of 5fC that changes base-pairing upon PCR 
amplification D) Two examples of chemical enrichment methods to pulldown 
modified bases. 5hmC can be chemoenzymatically enriched by coupling to 
Uridine-5’-(6-deoxy-6-azido--D-glucopyranosyl diphosphate) (UDP-6-Azido-
Glucose) and subsequent click reaction to a biotin linker to enable pull-down. 
 
 
Table 1| Approaches for mapping modified DNA bases.  
Base 
derivati
ve  
Chemical enrichment 
techniques 
Antibody 
Enrichment 
techniques  
Single-base 
resolution techniques 
5mC 
No technique 
published  
5Me-DIP133 
Bisulfite 
ox-BS76 
5hmC 
GLIB-seq134 
hMeSeal-seq135 
5hme-DIP136 
CMS-DIP134 
JBP1-DIP137 
TAB-seq77 
SCL-exo138 
AbaSI-seq72 
PvuRts1139 
5fC 
Aldehyde reactive 
probe140,27 
fCSeal-seq78 
5fC-DIP28 
fC-CET84 
red-BS24 
fCAB-seq78 
MAB-seq141 
CLEVER-seq142 
5caC 
No technique 
published 
5caC-DIP28 
DIP-Cab-seq143 
MAB-seq144 
5hmU 
KRuO4 / Aldehyde 
reactive probe54 
5hmU-DIP54 No technique published 
5fU 
Aldehyde reactive 
probe54 
No technique 
published 
No technique published 
Base J 
NaIO4 / Aldehyde 
reactive probe54 Base J-DIP56 
No technique published 
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6mA 
No technique 
published 
6mA-DIP63 6mA-RE-seq66 
 
GLIB-seq: Glucosylation, periodate oxidation and biotinylation 
sequencing 
 
hMe-Seal: 5hmC selective chemical labeling  
 
DIP: DNA immunoprecipitation 
 
SCL-exo: Selective chemical labeling-exonuclease digestion 
 
fCAB seq: 5fC chemically assisted bisulfite sequencing 
 
MAB-seq: Methylase assisted bisulfite sequencing 
 
CLEVER-seq: Chemical labeling enabled C-to-T conversion sequencing 
 
6mA-RE seq: 6mA restriction enzyme guided sequencing  
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Transcription factors: A protein that binds to a specific DNA sequence and 
thus controls the transcription of the genetic information from DNA to RNA. 
Restriction methylation: In bacteria or other prokaryotic systems, methylation 
to the DNA protects from restriction endonuclease enzymes providing a 
defense mechanism against invasions from bacteriophages or virus.  
Restriction endonucleases: Enzymes that cut DNA at endogenous 
phosphodiester bonds  
Promoters: Region of DNA that is located near to the transcription start site 
and controls transcription initiation  
Retrotransposons: Genetic elements that are transcribed into RNA, then 
reverse transcribed back into DNA and inserted into the genome.  
Genomic imprinting: Epigenetic marking of one copy of the gene (from mother 
or father) that ensures gene expression in a parent-of-origin specific manner. 
Transposon silencing: Gene silencing of transposons by epigenetic 
mechanisms, including DNA methylation and small non-coding RNA, prevents 
transcription and ensures genome stability.  
Histone modifications: Post-translational chemical modification to amino acid 
residues on histone. 
Chromatin-remodeling proteins: Proteins that control access to the genetic 
information by either affecting histone modifications or using energy to alter 
histone-DNA interactions.  
CpG islands: A region with high CpG dinucleotide density  
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Pluripotent stem cells: Cell that is able to differentiate into any other tissue of 
the body.  
Enhancer regions: Regulatory regions of the genome that are marked by 
histone modifications and enhance the transcription of their associated genes 
when bound to transcription factors   
Base excision repair: Cellular mechanism that removes small base lesions 
from the DNA caused by mismatched or modified DNA bases. 
Histone octamer: Consist of histone H2A, H2B, H3, H4 dimers that together 
form the core of the nucleosome 
B cells: Type of white blood cell that is fundamental to the adaptive immune 
system 
Class-switch recombination: A process whereby B cells rearrange parts of the 
immunoglobin heavy chain locus to generate antibodies with different 
properties  
Telomeric regions: Repetitive nucleotide sequences that protect the ends of 
chromosomes    
Repetitive elements: Repeat sequences that occur multiple times throughout 
the genome 
RNA polymerase II: Polymerase that catalyses the transcription of DNA to 
RNA 
Transfer RNA: An adapter RNA and amino acid carrier that helps decode 
messenger RNA for translation into the synthesis of proteins 
β-elimination: DNA cleavage at the phosphodiester bond resulting in the 
elimination of the 3’-phosphate residue  
δ-elimination: DNA cleavage at the phosphodiester bond resulting in the 
elimination of the 5’-phosphate residue  
Clustered regularly interspaced short palindromic repeats (CRISPR) systems: 
Repetitive base sequence that form the basis of the genome editing system 
known as CRISP/Cas9  
Transcription-activator like effectors (TALEs): Proteins that can be 
programmed to target specific DNA sequences in the genome.  
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Mapping and elucidating the function of modified bases in DNA 
Eun-Ang Raiber, Robyn Hardisty, Pieter van Delft and Shankar 
Balasubramanian 
Research into naturally occurring chemically modified DNA bases has been 
invigorated by new chemical and enzymatic methods that, when coupled with 
sequencing approaches, enable us to detect and decode them. These 
techniques will enable a better understanding of the role of chemically 
modified DNA bases in normal physiology and disease. 
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1) The first report on the double helical structure of DNA and the pairing of G-
C and A-T bases. 
13. Deaton, A. & Bird, A. CpG islands and the regulation of transcription. 
Genes Dev. 25, 1010–1022 (2011). 
This is a comprehensive review explaining the concept and importance of 
CGIs as regulatory features of the genome. 
23. Pfaffeneder, T. et al. The discovery of 5-formylcytosine in embryonic stem  
cell DNA. Angew Chem Int Ed Engl. 50, (2011) 
This work provides the first evidence of the existence of 5fC in embryonic 
stem cell. 
29) Work describing the timing of formation and metabolism of 5mC and 
5hmC in genomic DNA using LC-MS/MS and stable isotopes 
46) Work describing the use of stable isotopes and LC-MS/MS to elucidate 
the mechanism for 5-hmU formation in DNA 
62) The discovery, quantitation and mapping of N6-methyladenosine in the 
model animal C. elegans 
63) The discovery, quantitation and mapping of N6-methyladenosine in the 
model animal D. melanogaster 
76. Booth, M. J. et al. Quantitative sequencing of 5-methylcytosine and 5- 
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hydroxymethylcytosine at single-base resolution. Science 336, 934–
937 (2012) 
This article describes the development of a sequencing method that enabled 
the study of the dynamics and sequence context of 5hmC in mouse 
embryonic stem cell at single-base resolution for the first time  
82. Smallwood, S. A. et al. Single-cell genome-wide bisulfite sequencing for  
assessing epigenetic heterogeneity. Nat Meth 11, 817–820 (2014). 
This work describes the adaptation of the bisulfite sequencing method to 
single cells revealing 5mC heterogeneity within cell populations.    
121) The first report on the formation of 5hmC in mammalian genomes from 
5mC by the TET family of enzymes 
140. Raiber, E. A. et al. Genome-wide distribution of 5-formylcytosine in 
embryonic stem cells is associated with transcription and depends on 
thymine DNA glycosylase. Genome Biol. 13, (2012). 
This work provides the first genome-wide map of 5fC in embryonic 
stem cell demonstrating that the 5fC pattern was TDG-dependent.  
 
 
 
 
